$2.09
0.2412.97%
Pre-Market: Nov 19, 4:10 PM EDT
Comments
Loading...
Universe Pharmaceuticals (NASDAQ:UPC) Stock, Earnings Estimates, EPS, And Revenue
Universe Pharmaceuticals reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Jan 30
EPS
$-1.700
Quarterly Revenue
$32.3M
Annual Revenue
(as of Mar 31)
(as of Mar 31)
$26.7M
Analyze the earnings history of Universe Pharmaceuticals using advanced sorting and filters.
Data brought to you by Benzinga APIs
Universe Pharmaceuticals (UPC) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Jun 2021 | 2021-08-02 | $2.64 | $0.32 | 72500.0 % |
Universe Pharmaceuticals (UPC) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Jun 2021 | 2021-08-02 | $24.30M | $16.40M | 48.2 % |
FAQ
When is Universe Pharmaceuticals (NASDAQ:UPC) reporting earnings?
Universe Pharmaceuticals (UPC) is scheduled to report earnings on January 28, 2025. The last reported earnings were for reported on January 30, 2024 for FY.
What were the latest earnings per share (EPS) for Universe Pharmaceuticals (NASDAQ:UPC)?
The Actual EPS was $-1.70, which missed the estimate of $0.00.
What were Universe Pharmaceuticals’s (NASDAQ:UPC) revenues?
The Actual Revenue was $32.3M, which beat the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.